Our People

Shalika Charles

  • scharles@ardentadvisory.com
  • Abu Dhabi


Shalika is a consultant at ARDENT Advisory & Accounting and carries over 4 years of financial consultancy field experience in providing financial due diligence and sell-side advisory services. 

Prior to joining ARDENT recently, he was an associate at a Big 4 in Sri Lanka as part of its Deals Advisory team performing buy and sell-side FDDs across a range of industries, including financial services, insurance, hospitality, health care, renewable energy, manufacturing as well as retail and distribution.  

Shalika is an affiliate of the Association of Chartered Certified Accountants and past finalist of Chartered Institute of Management Accountants. He also hold a degree in business management from Staffordshire University (UK) and a MBA from University of the West of England – UWE Bristol (UK). 


Shalika has been involved in M&A transaction due diligence and Buy Side Advisory in Sri Lanka and UAE, working with large corporate clients, PE houses, sovereign funds as well as HNIs. 

Some of his transactions involved assisting clients in:  

  • Buy-side FDD to assist Norwegian and Finland sovereign funds on their investment of one of the largest life insurance companies, based in Sri Lanka; 
  • Buy-side FDD to assist a Norwegian based private equity on their investment in one of the most significant information technology companies in Sri Lanka; 
  • Vendor due diligence to assist a leading non-banking financial institution based in Sri Lanka, for them to raise capital to be in line with the minimum capital requirement imposed by Sri Lanka; 
  • Buy-side FDD to assist the largest cement manufacturing company in Sri Lanka on their proposed investment of cement bagging operations based in the Maldives; 
  • Buy-side FDD to assist a Singaporean based private equity firm on their proposed investment in one of the largest apartment complex construction projects in Sri Lanka; and 
  • Buy-side FDD to assist a leading investment company with their proposed investment in a pharmaceutical and healthcare distribution company in the UAE.